With just under 60% of the amount spent in the U.S., European health authorities bought close to 500,000 more biopsy needles for breast cancer treatment and prevention. According to breast cancer biopsy market data released by iData Research (www.idataresearch.com), the European health authorities brought almost 500,000 more biopsy needles in 2013.

READ FULL ARTICLE Curated publisher From PR Newswire